thc


The Green Organic Dutchman launches exciting new products Fall 2022 in British Columbia, Alberta & Ontario

September 21st, 2022 - Ryan Allway

7 core SKU expansions in BC and Alberta 4 new innovative products launch, starting in Ontario   TORONTO, Sept. 21, 2022 /PRNewswire/ – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD“) (CSE: TGOD) (US-OTC: TGODF), a sustainable cannabis company, announces new Fall 2022 SKU launches.   With record yields and increased growing capacity, the organization will now […]

IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC

September 21st, 2022 - Ryan Allway

POTOMAC, Md., September 21, 2022–(BUSINESS WIRE)–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced today that the United States Patent and Trademark Office (“USPTO”) issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”   The original […]

Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles

September 21st, 2022 - Ryan Allway

The new and improved products are derived from novel proprietary cannabis varieties developed using genetic markers utilizing Evogene’s GeneRator AI tech-engine   REHOVOT, Israel, Sept. 21, 2022 /PRNewswire/ — Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. ( Nasdaq: EVGN, TASE: EVGN), today announced the launch of its second-generation products in Israel. […]

Ovation Science Strengthens IP Protection with New US Patent

September 14th, 2022 - Ryan Allway

Patent Protection Until 2041 Awarded for Transdermal Creams Formulated with CBD and THC   VANCOUVER, BC and LAS VEGAS, Sept. 14, 2022 /CNW/ – (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce that the U.S. Patent and […]

Irwin Naturals THC Products to Be Available in Michigan

August 31st, 2022 - Ryan Allway

Company announces licensing agreement with Michigan company to produce and distribute Irwin Naturals THC products   LOS ANGELES, Aug. 31, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today a licensing agreement with 42 Degrees Processing LLC (“42 Degrees”), through its subsidiary Irwin Naturals Cannabis, Inc., to produce […]

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug

July 12th, 2022 - Ryan Allway

Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Diversifies Akanda into cancer pain medical market as a specialized manufacturer of cannabis-based drugs for use in FDA clinical trials and pharmaceutical markets   LONDON & MONTREAL–(BUSINESS WIRE)–Akanda Corp. (“Akanda”) (NASDAQ: AKAN) and Tetra Bio-Pharma (“Tetra”) (TSX: […]

Vext Announces $22.2 Million Credit Facility

July 8th, 2022 - Ryan Allway

Credit facility composed of two secured term loans bearing interest at 7.5%. Will be used to retire current secured debt, which currently bears an average rate of 10%. All currency is presented in USD.   VANCOUVER, BC, July 8, 2022 /CNW/ – Vext Science, Inc. (“Vext” or the “Company”) (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, […]

Mary Jones – 1st Cannabis Soda with Real Soda Taste – Debuts in California

June 22nd, 2022 - Ryan Allway

– Four Fan-Favorite Jones Soda Flavors Infused with THC Take Flavors Higher –   SEATTLE, June 22, 2022 /PRNewswire/ — Get ready for the best tasting brand in cannabis, available now in California. After 25 years of creating signature craft soda flavors and famously featuring fan-submitted photo labels on every bottle, Jones Soda Co. is entering a whole new category […]

KIVA Sales and Service Secures Distribution Partnership with JONES SODA CO.

June 22nd, 2022 - Ryan Allway

Kiva Sales and Service Will Assist Jones Soda Co. In Launching Their First-Ever Cannabis-Infused Beverage, Mary Jones, Into The California Market   OAKLAND, Calif., June 22, 2022 /PRNewswire/ — Jones Soda Co. (OTCQB: JSDA) (CSE: JSDA), the original craft soda known for its unconventional flavors and user photo-submitted labels, today announced an exclusive partnership with […]

IGC Reports Financial Results for Fiscal Year Ended March 31, 2022

June 22nd, 2022 - Ryan Allway

June 22, 2022, 11:26 PM EDT POTOMAC, Md.–(BUSINESS WIRE)–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces its financial results for Fiscal Year Ended March 31, 2022.   Highlights for Fiscal 2022: IGC completed the first-in-human safety and tolerability trial on its tetrahydrocannabinol (THC) based investigational new drug IGC-AD1. During the trial, […]

Irwin Naturals Files Q1 2022 Financials

May 30th, 2022 - Ryan Allway

Cannabis Licensing and Ketamine Clinic Rollup Strategy Accelerating Growth Company to host conference call Tuesday, May 31, 2022 at 2:00 pm EST LOS ANGELES, May 30, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its first quarter of fiscal 2022, the period ended […]

MariMed Receives Media Awards For “World’s Largest Cannabis Brownie” PR Campaign

May 24th, 2022 - Ryan Allway

NORWOOD, Mass., May 24, 2022 (GLOBE NEWSWIRE) — MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced its recent “World’s Largest Cannabis Brownie” public relations campaign has earned two of the most prestigious national communications awards for its effectiveness in driving visibility of the Company and its Bubby’s Baked infused baked […]

New Independent Study Correlates THC in Breath and Blood using Cannabix Technology

May 16th, 2022 - Ryan Allway

The legalization of cannabis promises to solve many of society’s problems and unlock new economic opportunities. However, the move also creates new challenges for law enforcement. For instance, studies suggest that cannabis may acutely impair several driving-related skills in a dose-related fashion, but there’s no easy roadside test available. Cannabix Technologies Inc. (CSE: BLO) (OTC: […]

ALLIED CORP Announces Approval Of Psychoactive (THC) Quota For The Production Of Colombian THC Cannabis Flower

May 3rd, 2022 - Ryan Allway

KELOWNA, British Columbia, May 03, 2022 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce the approval of its 2022 quota for the production and sale of THC cannabis flower. On April 29th, 2022 the Colombian government approved Allied’s application for its THC cannabis flower quota for the 2022 calendar year. […]

Solei Brand Launches New Wellness Product For Nighttime Use

March 24th, 2022 - Ryan Allway

Renew ‘Moonlight’ by Solei, CBN Vape Pen, Now Available Across Canada   TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced the launch […]

INDIVA Launches New Cannabis Edible Formulated For Night-Time Use

February 15th, 2022 - Ryan Allway

New Wana Quick Midnight Berry Indica gummies offer a unique formulation of CBN, CBD, THC, and a proprietary terpene blend recommended for night-time use   LONDON, ON, Feb. 15, 2022 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSXV: NDVA) (OTCQX: NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is taking an even bigger […]

IGC Reports Financial Results for the December 31, 2021 Quarter

February 10th, 2022 - Ryan Allway

POTOMAC, Md., February 10, 2022–(BUSINESS WIRE)–India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the three months ending December 31, 2021 – quarter three of the Company’s 2022 fiscal year.   Highlights include: The Company appointed former congressman James Moran to its Board of Directors. During his 24 years in Congress, Moran […]

Audacious Firing on all Cylinders

January 26th, 2022 - Ryan Allway

LAS VEGAS, Jan. 26, 2022 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA“, “AUDACIOUS” or the “Company“) is pleased to provide the following corporate update:   Australis Capital Inc. logo (CNW Group/Australis Capital Inc.) “We are executing both within the U.S. and internationally, rapidly expanding our footprint, brand recognition and product offerings, while developing new […]

Xebra Granted Trademarks in the European Union

January 18th, 2022 - Ryan Allway

VANCOUVER, BC, Jan. 18, 2022 /PRNewswire/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that it has been granted trademarks in the European Union, covering 28 countries and 10 territories, for Xebra’s THC and CBD infused beverage brands, including MADCAP soft drinks, and the slogan Crazy Good, HOLAHI iced teas and the slogan It’s High […]

Skye Bioscience Issues Shareholder Letter Providing Progress Update and Business Outlook for 2022

January 10th, 2022 - Ryan Allway

SAN DIEGO, CA, Jan 10, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing proprietary, synthetic, cannabinoid-derived molecules to treat diseases with significant unmet need, issued today the following letter from Chief Executive Officer and Chair, Punit Dhillon. Dear Shareholders, Colleagues and Collaborators, I would like to thank you for […]

Xebra Begins Formal THC Cannabis Cultivation In The Netherlands

January 6th, 2022 - Ryan Allway

VANCOUVER, BC, Jan. 6, 2022 /CNW/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTC: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that it has commenced formal cannabis cultivation in the Netherlands, including THC varietals.   Xebra Brands Ltd. Logo (CNW Group/Xebra Brands Ltd.) As 1 of only 5 companies to be selected by the Dutch government to […]

Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients

December 8th, 2021 - Ryan Allway

POTOMAC, MD,, December 08, 2021–(BUSINESS WIRE)–(NYSE American: IGC), India Globalization Capital, Inc. (IGC) today announces preliminary results for its exploratory endpoints from its Phase 1 IGC-AD1 clinical trial. IGC-AD1 is a proprietary cannabis-based investigational new drug candidate for patients suffering from Alzheimer’s disease. The Phase 1 clinical trial provided valuable insights on Pharmacokinetics (PK) and […]

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

December 2nd, 2021 - Ryan Allway

POTOMAC, Md., December 02, 2021–(BUSINESS WIRE)–(NYSE American: IGC), India Globalization Capital, Inc. (IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. The results of the clinical […]

Pure Harvest Corporate Group Reports Third Quarter Results and Provides Corporate Update from CEO in Letter to Shareholders

November 16th, 2021 - Ryan Allway

GREENWOOD VILLAGE, CO, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Pure Harvest Corporate Group, Inc. (OTCQB: PHCG), a vertically integrated consumer products holding company focused on cutting edge plant-based nutraceuticals, recreational cannabis, hemp-derived health and wellness products, and other emerging industries, is excited to issue an open letter to shareholders from its CEO, Matthew Gregarek.   Dear […]

WestCann: A Unique Business Model with Plenty of Catalysts Ahead

November 11th, 2021 - Ryan Allway

The legal cannabis industry has grown from humble beginnings in the early 2000s into a multi-billion dollar global industry. In addition to THC-containing products capturing market share from the black market, CBD and other cannabinoids have exploded onto the health and wellness scene as researchers continue to uncover potential benefits. Of course, a license to […]

Agra Ventures Subsidiary Farmako Launches New THC and CBD Testkit to German Pharmacies

October 14th, 2021 - Ryan Allway

The Proprietary Testkits Perform Identity Testing of Both THC and CBD in Cannabis Products   VANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) — Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (Frankfurt: PU30) (OTCPK: AGFAF), a growth-oriented and diversified company focused on the international cannabis industry, is pleased to announce that its wholly owned subsidiary, Farmako GmbH (“Farmako”), has expanded its portfolio of cannabis […]

Skye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies

August 10th, 2021 - Ryan Allway

THCVHS shows no signs of chromosomal or gene mutations in preclinical studies SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, has successfully completed genotoxicity studies of THCVHS required prior to beginning its planned […]

BC Craft Supply Co Announces Provision Patent for Custom Cannabis Micro-Dosing Tablet Dispenser

July 26th, 2021 - Ryan Allway

VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co Ltd., (CSE: CRFT) (“CRFT” or the “Company”), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, is pleased to announce that its subsidiary, FeelWell Brands Inc. (“FeelWell”) has filed a provisional patent application in the United States Patent and Trademark […]

Data Analysis Yields Insights Into Medical Cannabis Use, Efficacy

June 21st, 2021 - Robin Lefferts

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. Every major professional sport is undergoing an analytics revolution. Pharmaceutical companies use artificial intelligence (AI) to […]

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

June 10th, 2021 - Ryan Allway

OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company, (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.   Currently, CURE uses its Schedule 1 DEA license for the development […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading